Authors/Disclosures
|
Neeraj Badjatia, MD
(University of Maryland School of Medicine)
|
The institution of Dr. Badjatia has received research support from NIH/DOD. |
|
Luis Fernandez
|
No disclosure on file |
|
Andres Fernandez, MD
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Christine A. De Meulemeester, MD
|
No disclosure on file |
|
Augusto Parra, MD, MPH
(Hartford Hospital/ Hartforf Health Care)
|
Dr. Parra has nothing to disclose. |
|
Stephan A. Mayer, MD
(Henry Ford Hospital)
|
Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Phagenesis. Dr. Mayer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Astra Zeneca. Dr. Mayer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. Dr. Mayer has stock in Neuroptics. Dr. Mayer has received publishing royalties from a publication relating to health care. |